LIFE News and Press, aTyr Pharma Inc. From 05/06/19

SAN DIEGO, May 06, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it will report first quarter 2019 results after the market clo...

SAN DIEGO, April 16, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that the Company will host a summit meeting on Neuropilin-2 (NRP-...

ATyr Pharma (NASDAQ: LIFE ) agrees to sell ~9.2M shares at $0.541 per share yielding $5M to The Federated Kaufmann Small Cap Fund and existing shareholder Paul Schimmel, Ph.D., in a registered direct offering. More news on: aTyr Pharma, Inc., Healthcare stocks news, Read more .....

SAN DIEGO, April 11, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it has entered into a definitive agreement with The Federate...

SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that the Company will present an abstract in a poster presentatio...

aTyr Pharma, Inc. (LIFE) Q4 2018 Earnings Conference Call March 25, 2019 05:00 PM ET Company Participants Jill Broadfoot - CFO Sanjay Shukla - CEO Conference Call Participants Shawn Egan - Citi Katherine Xu - William Blair Presentation Operator Good afternoon, lad...

aTyr Pharma (NASDAQ: LIFE ): Q4 GAAP EPS of -$0.21. More news on: aTyr Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Phase 1b/2a proof-of-concept clinical trial of ATYR1923 in pulmonary sarcoidosis patients initiated in December 2018 First tRNA synthetase partnership announced in March 2019 SAN DIEGO, March 25, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company en...

SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that data from its successful pilot study with the University of ...

SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it will report fourth quarter and full year 2018 financial r...